CYCCP Share Price

Open 0.00 Change Price %
High 6.20 1 Day -0.44 -6.63
Low 6.20 1 Week 0.39 6.71
Close 6.20 1 Month -0.42 -6.34
Volume 210 1 Year 0.40 6.90
52 Week High 11.29
52 Week Low 0.00
CYCCP Important Levels
Resistance 2 6.20
Resistance 1 6.20
Pivot 6.20
Support 1 6.20
Support 2 6.20
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
DCTH 0.24 -11.11%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
ORCL 50.30 8.57%
ORCL 50.30 8.57%
ORCL 50.30 8.57%
RFMD 16.59 -2.07%
More..
NASDAQ USA Top Gainers Stocks
GCFB 0.95 58.33%
FALC 0.38 52.00%
LOCM 0.09 50.00%
ENOC 7.65 41.67%
TROV 1.30 36.84%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
AMRS 3.29 21.40%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
PTSX 0.12 -40.00%
More..

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCCP)

CYCCP Technical Analysis 3
As on 21st Jun 2017 CYCCP Share Price closed @ 6.20 and we RECOMMEND Sell for LONG-TERM with Stoploss of 6.22 & Sell for SHORT-TERM with Stoploss of 6.58 we also expect STOCK to react on Following IMPORTANT LEVELS.
CYCCP Target for June
1st Target up-side 9.99
2nd Target up-side 12.52
3rd Target up-side 15.05
1st Target down-side 2.77
2nd Target down-side 0.24
3rd Target down-side -2.29
Cyclacel Pharmaceuticals, Inc. ( NASDAQ USA Symbol : CYCCP )
Sector : N/AIndustry:N/AFull Time Employees:18Business Summary Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. The company’ And Other Stocks in Same Sector
CYCCP
6.20 -0.44 (-6.63 %)
LT : Sell
ST : Sell
CYCCP Other Details
Segment EQ
Market Capital 4901093.50
Sector N/AIndustry:N/AFull Time Employees:18Business Summary Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. The company’
Industry N/AFull Time Employees:18Business Summary Cyclacel Pharmaceuticals, Inc., a development-stage b
Offical website http://www.cyclacel.com
CYCCP Address
CYCCP
200 Connell Drive
Suite 1500
Berkeley Heights, NJ 07922
United States
Phone: 908-517-7330
Fax: 866-271-3466
CYCCP Latest News
Interactive Technical Analysis Chart Cyclacel Pharmaceuticals, Inc. ( CYCCP NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cyclacel Pharmaceuticals, Inc.
CYCCP Business Profile
Cyclacel Pharmaceuticals, Inc. develops therapies that harness the power of the immune system to treat cancer and other serious illnesses. The Company develops proprietary techniques of antibody engineering to develop antibody-based products for the applications in immunology, oncology, and infectious diseases. Xcyte Therapies is currently conducting Phase I/II clinical trials in hormone-refractory prostate cancer, multiple myeloma and chronic lymphocytic leukemia.